{"version":"1.0","provider_name":"BMJ Sexual &amp; Reproductive Health blog","provider_url":"https:\/\/blogs.bmj.com\/bmjsrh","author_name":"eleanorlee","author_url":"https:\/\/blogs.bmj.com\/bmjsrh\/author\/eleanorlee\/","title":"Breaking Barriers: Japan's market test of emergency contraceptive pills and their intermediate results - BMJ Sexual &amp; Reproductive Health blog","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"MMM7OSIb1z\"><a href=\"https:\/\/blogs.bmj.com\/bmjsrh\/2024\/06\/24\/japans-market-test-of-emergency-contraception\/\">Breaking Barriers: Japan&#8217;s market test of emergency contraceptive pills and their intermediate results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.bmj.com\/bmjsrh\/2024\/06\/24\/japans-market-test-of-emergency-contraception\/embed\/#?secret=MMM7OSIb1z\" width=\"600\" height=\"338\" title=\"&#8220;Breaking Barriers: Japan&#8217;s market test of emergency contraceptive pills and their intermediate results&#8221; &#8212; BMJ Sexual &amp; Reproductive Health blog\" data-secret=\"MMM7OSIb1z\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.bmj.com\/bmjsrh\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"By Hayase Hakariya &nbsp; The Japanese government finally initiated a market test to sell emergency contraceptive pills (ECPs), levonorgestrel (approved in 2011 in Japan), or its generic product, at the designated pharmacies on 28th November 2023. This has been achieved through the long-lasting 6-year endeavours by individuals or voluntary groups to voice easier access for [...]Read More..."}